Geode Capital Management
PMVP icon

Geode Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Geode Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Sell
473,158
-22,764
-5% -$29.2K ﹤0.01% 3513
2026
Q1 		$615K Buy
495,922
+49,782
+11% +$63.3K ﹤0.01% 3516
2025
Q4 		$558K Buy
446,140
+14,320
+3% +$19.2K ﹤0.01% 3553
2025
Q3 		$605K Sell
431,820
-884
-0.2% -$1.22K ﹤0.01% 3544
2025
Q2 		$459K Buy
432,704
+1,912
+0.4% +$1.88K ﹤0.01% 3583
2025
Q1 		$470K Buy
430,792
+9,082
+2% +$12.3K ﹤0.01% 3564
2024
Q4 		$637K Sell
421,710
-11,052
-3% -$17.5K ﹤0.01% 3535
2024
Q3 		$645K Buy
432,762
+5,038
+1% +$7.78K ﹤0.01% 3512
2024
Q2 		$693K Sell
427,724
-475,413
-53% -$857K ﹤0.01% 3454
2024
Q1 		$1.54M Buy
903,137
+42,801
+5% +$79.9K ﹤0.01% 3215
2023
Q4 		$2.67M Buy
860,336
+52,773
+7% +$140K ﹤0.01% 2999
2023
Q3 		$4.96M Buy
807,563
+62,229
+8% +$428K ﹤0.01% 2647
2023
Q2 		$4.67M Buy
745,334
+79,223
+12% +$415K ﹤0.01% 2722
2023
Q1 		$3.18M Buy
666,111
+15,936
+2% +$112K ﹤0.01% 2830
2022
Q4 		$5.66M Buy
650,175
+5,034
+0.8% +$53.7K ﹤0.01% 2603
2022
Q3 		$7.68M Buy
645,141
+79,608
+14% +$1.15M ﹤0.01% 2430
2022
Q2 		$8.06M Buy
565,533
+113,030
+25% +$1.65M ﹤0.01% 2408
2022
Q1 		$9.42M Sell
452,503
-5,825
-1% -$103K ﹤0.01% 2383
2021
Q4 		$10.6M Buy
458,328
+24,855
+6% +$601K ﹤0.01% 2405
2021
Q3 		$12.9M Buy
433,473
+85,292
+24% +$2.72M ﹤0.01% 2275
2021
Q2 		$11.9M Buy
348,181
+102,095
+41% +$3.41M ﹤0.01% 2341
2021
Q1 		$8.09M Buy
246,086
+242
+0.1% +$9.54K ﹤0.01% 2507
2020
Q4 		$15.1M Buy
245,844
+212,844
+645% +$8.35M ﹤0.01% 1890
2020
Q3 		$1.17M Buy
+33,000
New +$1.21M ﹤0.01% 3146

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management's PMVP Position: Q2 2026 in Review

Geode Capital Management reduced its PMV Pharmaceuticals (PMVP) stake by 4.6% in Q2 2026, selling an estimated $29.2K and leaving 473,158 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

Geode Capital Management first reported a position in PMVP in Q3 2020 and has held it in 24 quarters since. The position peaked at $15.1M in Q4 2020. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Geode Capital Management held 473,158 shares of PMV Pharmaceuticals worth $635K as of Q2 2026.
  • Geode Capital Management sold 22,764 PMV Pharmaceuticals shares in Q2 2026, an estimated $29.2K.
  • PMV Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3513 holding.
  • Geode Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Geode Capital Management's PMV Pharmaceuticals position peaked at $15.1M in Q4 2020.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.